Independent since 2009
Investment and advisory judgment tested across market cycles.
Complex decisions.
Clear direction.
Research. Strategy. Value.
Why HER4
Experience without the overhead.
Institutional rigor
Research built to support real capital decisions.
Fractional leadership
Senior capability—precisely when it is needed.
Accountable advice
Independent assessments with explicit assumptions, risks, and recommendations.
Services
Research that informs the decision.
Investment underwriting, strategic finance, life-science diligence, and competitive analysis grounded in evidence and real transaction experience.
Investment Research & Underwriting
Find the signal, define the risk, and translate rigorous analysis into a defensible capital decision.
Strategic & Financial Advisory
Turn complexity into an executable plan with senior-level financial and operating judgment.
Life-Science Diligence
Connect scientific evidence, clinical differentiation, commercial reality, and value.
Positioning & Competitive Intelligence
Build a credible story that anticipates scrutiny and clarifies the strategic landscape.
About
The advantage is range.
Harry Russell brings 30 years of investing, underwriting, and strategic finance across public and private markets, with deep experience in healthcare, biotechnology, and litigation finance. His work spans Palladin, Hildene, Dislocation, and ACI.
30Years of experience
$1B+Cumulative capital managed across public and private investments
$500M+Direct investments across equity, credit, and litigation finance
55Direct investments structured and executed
Built in the real world
Investor and research leader
Harry combines fundamental research with capital engineering: shaping securities, contractual protections, and hedges around a business’s risks and financing needs, then adapting investments as conditions change.
Direct senior support
Advisor and operator
His work spans research leadership, fractional CFO support, strategic finance, healthcare and scientific diligence, and independent advice when a decision needs more than a standard answer.
HER4, since 2009
The through-line—not a reinvention.
For more than fifteen years, Harry has advised investors, founders, and leadership teams while also holding demanding institutional roles.
Education
Technical depth. Financial discipline.
MS, BiotechnologyJohns Hopkins University
MBA, FinanceFairleigh Dickinson University
BS, Biomedical EngineeringRensselaer Polytechnic Institute
Capabilities & perspectives
Thinking worth using.
Useful thinking for leaders facing consequential questions in capital markets, corporate strategy, and life sciences.
Therapeutic Perspectives
The science behind
the difference.
Our research library compares competing therapies and explains emerging science—starting with the biology, testing the evidence and separating demonstrated benefits from hypotheses.
Explore Therapeutic Perspectives →Latest combined feature · October 30, 2026
Beyond GLP-1: Can triple agonists move the needle?
From semaglutide and tirzepatide to retatrutide and amylin: how the hormonal pathways differ, what the trials show and where the next generation may lead.
Read the expanded feature →Start a conversation
Bring the difficult question.
The best engagements begin with a consequential question—and a candid conversation about what the evidence really says.
Harry Russell
harry@her4consulting.comShare a short description of the organization, opportunity, or decision involved—and the timing of your project.